Atlas Trials

Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer

Clinical trial NCT07016724 · RECRUITING

Trial details

NCT number
NCT07016724
Sponsor
The First Affiliated Hospital of Zhengzhou University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Squamous Cell Carcinoma
Start date
2024-08-15
Primary completion
2026-08-31
Enrollment
208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.